Role of platelet glycoprotein polymorphisms in cardiovascular diseases

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 1, 2004, Pages 38-54

  Meisel, Christian ^a   López, José A ^b   Stangl, Karl ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular diseases; Genetic susceptibility; Pharmacogenomics; Platelet glycoprotein; Polymorphism

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ESTROGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORBOFIBAN; RISTOCETIN; THROMBIN RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2;

ACUTE HEART INFARCTION; ALLELE; ARTERY THROMBOSIS; ATHEROGENESIS; BLEEDING TIME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DEGRANULATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INCIDENCE; MORTALITY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOGENOMICS; PROTEIN FUNCTION; RESTENOSIS; REVIEW; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOGENESIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ALLELES; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC;

EID: 0742321740     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0828-y     Document Type: Review

References (131)

1. Abbate R, Marcucci R, Camacho-Vanegas O, Pepe G, Gori AM, Capanni M, Simonetti I, Prisco D, Gensini GF (1998) Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 82:524-525
2. Afshar Kharghan V, Li CQ, Khoshnevis Asl M, Lopez JA (1999) Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186-191
3. Aleksic N, Juneja H, Folsom AR, Ahn C, Boerwinkle E, Chambless LE, Wu KK (2000) Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 102:1901-1905
4. Anderson JL, King GJ, Bair RL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF (1999) Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 33:727-733
5. Andrews R, Shen Y, Gardiner E, Dong J, Lopez J, Berndt M (1999) The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 82:357-364
6. Andrioli G, Minuz P, Solero P, Pincelli S, Ortolani R, Lussignoli S, Bellavite P (2000) Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol 110:911-918
7. Ardissino D, Mannucci, PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94:46-51
8. Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117-1122
9. Baker RI, Eikelboom J, Lofthouse E, Staples N, Afshar-Kharghan V, Lopez JA, Shen Y, Berndt MC, Hankey G (2001) Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98:36-40
10. Benze G, Heinrich J, Schulte H, Rust S, Nowak-Gottl U, Tataru MC, Kohler E, Assmann G, Junker R (2002) Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 23:325-330
11. Boden WE, McKay RG (2001) Optimal treatment of acute coronary syndromes - an evolving strategy. N Engl J Med 344: 1939-1942
12. Bottiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schomig K, von Beckerath N, Schomig A (2000) HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83: 559-562
13. Boudoulas KD, Cooke GE, Roos CM, Bay PF, Goldschmidt-Clermont (2001) The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med 125:112-115
14. Bray PF, Barsh G, Rosa JP, Luo XY, Magenis E, Shuman MA (1988) Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 85:8683-8687
15. Cadroy Y, Sakariassen KS, Charlet JP, Thalamas C, Boneu B, Sie P (2001) Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 98:3159-3161
16. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A (1999) The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93:3583-3586
17. Carter AM, Ossei-Gerning G, Grant PJ (1996) Platelet glycoprotein IIIa PlA polymorphism in young men with myocardial infarction. Lancet 348:485-486
18. Carter AM, Catto AJ, Bamford JM, Grant PJ (1998) Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 18:1124-1131
19. Casorelli I, De Stefano V, Leone AM, Chiusolo P, Burzotta F, Paciaroni K, Rossi E, Andreotti F, Leone G, Maseri A (2001) The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol 114:150-15
20. Coller BS (1995) Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 92:2373-2380
21. Coller BS (1997) Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 99:1467-1471
22. Corral J, Gonzalez-Conejero R, Rivera J, Iniesta JA, Lozano ML, Vicente V (1997) HPA-1 genotype in arterial thrombosis - role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 8:284-290
23. Corral J, Lozano ML, Gonzalez-Conejero R, Martinez C, Iniesta JA, Rivera J, Vicente V (2000) A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 83:23-28
24. Croft SA, Hampton KK, Sorrell JA, Steeds RP, Channer KS, Samani NJ, Daly ME (1999) The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol 106:771-776
25. Di Paola J, Federici AB, Mannucci PM, Canciani MT, Krtizik M, Kunicki TJ, Nugent D (1999) Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93:3578-3582
26. Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ, Tuddenham EG (2002) Platelet membrane glycoprotein Ibalpha gene - 5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 87:70-74
27. Durante-Mangoni E, Davies GJ, Ahmed N, Ruggiero G, Tuddenham EG (1998) Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism. Thromb Haemost 80: 218-219
28. Feng D, Lindpaintner K, Larson MG, Rao VS, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Silbershatz, D'Agostino RB, Muller JE, Myers RH, Levy D, Tofler GH (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19:1142-1147
29. Feng D, Lindpaintner K, Larson MG, O'Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D'Agostino RB, Levy D, Tofler GH (2001) Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: the Framingham Heart Study. Circulation 104:140-144
30. Frederickson BJ, Dong JF, McIntire LV, Lopez JA (1998) Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 92:3684-3693
31. French DL, Seligsohn U (2000) Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia. Arterioscler Thromb Vasc Biol 20:607-610
32. Furihata K, Nugent DJ, Kunicki TJ (2002) Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis. Arch Pathol Lab Med 126:305-309
33. Garcia-Ribes M, Gonzalez-Lamuno D, Hernandez-Estefania R, Colman T, Pocovi M, Delgado-Rodriguez M, Garcia-Fuentes M, Revuelta JM (1998) Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost 79:1126-1129
34. Gardemann A, Humme J, Stricker J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W (1998) Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 80:214-217
35. George JN, Caen JP, Nurden AT (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 75:1383-1395
36. Gonzalez Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V (1998) Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 92:2771-2776
37. Goodall AH, Curzen N, Panesar M, Hurd C, Knight CJ, Ouwehand WH, Fox KM (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20:742-747
38. Hato T, Minamoto Y, Fukuyama T, Fujita S (1997) Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 80:1222-1224
39. Hermann SM, Poirier O, Marques-Vidal P, Evans A, Arveiler D, Luc G, Emmerich J, Cambien F (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Thromb Haemost 77:1179-1181
40. Ioannidis JP, Ntzani EE, Trikanlinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
41. Ishida F, Furihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, Furuta S (1995) The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Blood 86:1357-1360
42. Ishida F, Ito T, Takei M, Shimodaira S, Kitano K, Kiyosawa K (2000) Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 111: 1247-1249
43. Ito T, Ishida F, Shimodaira, Kitano K (1999) Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease. Int J Hematol 70:47-51
44. Jacquelin B, Tarantino MD, Kritzik M, Rozenshteyn D, Koziol JA, Nurden AT, Kunicki TJ (2001) Allele-dependent transcriptional regulation of the human integrin alpha2 gene. Blood 97:1721-1726
45. Jilma-Stohlawetz P, Homoncik M, Jilma B, Knechtelsdorfer M, Unger P, Mannhalter C, Santoso S, Panzer S (2003) Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 120:652-655
46. Kaiser R, Tremblay PB, Roots I, Brockmoller J (2002) Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35:49-56
47. Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ (2002) Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32:643-648
48. Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt (1994) Localization of the Br polymorphism on a 144 bp exon of the GPIa gene and its application in platelet DNA typing. Thromb Haemost 71:651-654
49. Kastrati A, Schomig A, Seyfarth M, Koch W, Elezi S, Bottiger C, Mehilli J, Schomig K, von Beckerath N (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99:1005-1010
50. Kastrati A, Koch W, Gawaz M, Mehilli J, Bottiger C, Schomig K, von Beckerath N, Schomig A (2000) PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol 36:84-89
51. Kekomäki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, Kontula K (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 6:13-17
52. Kenny D, Muckian C, Fitzgerald DJ, Cannon CP, Shields DC (2002) Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 13:13-19
53. Kozak M (1981) Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res 9:5233-5262
54. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ (1998) Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92:2382-2388
55. Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S (2000) The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 83:392-396
56. Kuijpers RW, Faber NM, Cuypers HT, Ouwehand WH, von dem Borne AE (1992a) NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 89:381-384
57. Kuijpers RW, Ouwehand WH, Bleeker PM, Christie D, von dem Borne AE (1992b) Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha. Blood 79:283-288
58. Kunicki TJ (2002) The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 22:14-20
59. Kunicki TJ, Orchekowski R, Annis D, Honda Y (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82: 2693-2703
60. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ (1997) Hereditary variation in platelet integrin alpha 2 beta 1 density is associated with two silent polymorphisms in the alpha 2 gene coding sequence. Blood 89:1939-1943
61. Lanza F, Kieffer N, Phillips DR, Fitzgerald LA (1990) Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta-subunit gene. J Biol Chem 265:18098-18103
62. Laule M, Cascorbi I, Stangl V, Bielecke C, Wernecke KD, Mrozikiewicz PM, Felix SB, Roots I, Baumann G, Stangl K (1999) A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 253:708-712
63. Li CQ, Garner SF, Davies J, Smethurst PA, Wardell MR, Ouwehand WH (2000) Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 95:205-211
64. Lopez JA, Dong JF (1997) Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 4:323-329
65. Lopez JA, Ludwig EH, McCarthy BJ (1992) Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 267:10055-10061
66. Lopez JA, Andrews RK, Afshar Kharghan V, Berndt MC (1998) Bernard-Soulier syndrome. Blood 91:4397-4418
67. Mamotte CD, van Bockxmeer FM, Taylor RR (1998) PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 82:13-16
68. Marian AJ, Brugada R, Kleiman NS (1996) Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 335:1071-1072; discussion 1073-1074
69. Mazzucato M, Pradella P, de Angelis V, Steffan A, de Marco L (1996) Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Ib alpha in an Italian population. Transfusion 36:891-894
70. Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M (2001) In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 112: 621-631
71. Meisel C, Laule M, Cascorbi I, Herrmann A, Stangl V, Roots I, Stangl K (2000a) The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventions. Blood 96:2002-2003
72. Meisel C, Roots I, Cascorbi I, Brinkmann U, Brockmöller J (2000b) How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport. Clin Chem Lab Med 38:869-876
73. Meisel C, Afshar Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, Baumann, Lopez JA, Roots I, Stangl K (2001) Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 38:1023-1027
74. Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmöller J, Roots I (2003) Implications of pharmacogenetics for individualising drug treatment and for study design. J Mol Med 81:154-167
75. Mercier B, Munier S, Berault V, Mansourati J, Blanc JJ, Ferec C (2000) Myocardial infarction: absence of association with VNTR polymorphism of GP Ibalpha. Thromb Haemost 84:921-922
76. Michelson AD, Furman MI, Goldschmidt-Clermont P, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Barnard MR, Kickler T, Christie DJ, Kundu S, Bray PF (2000) Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 101:1013-1018
77. Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttila A, Karhunen PJ (1999) Glycoprotein IIIa PlA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscl Thromb Vasc Biol 19:2573-2578
78. Mikkelson J, Perola M, Penttila A, Karhunen PJ (2001) Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104:876-880
79. Miller JL (1996) Platelet-type von Willebrand disease. Thromb Haemost 75:865-869
80. Morita H, Kurihara H, Imai Y, Sugiyama T, Hamada C, Sakai E, Mori M, Nagai R (2001) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 85:226-230
81. Moroi M, Jung SM, Yoshida N (1984) Genetic polymorphism of platelet glycoprotein Ib. Blood 64:622-629
82. Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353: 351-354
83. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM (1992) Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Blood 79:3086-3090
84. Murata M, Matsubara Y, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96:3281-3286
85. Newman PJ (1997) Platelet alloantigens: cardiovascular as well as immunological risk factors? Lancet 349:370-371
86. Newman PJ, Derbes RS, Aster RH (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/ proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83: 1778-1781
87. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470-472
88. Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ (1986) Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 68:692-695
89. Nurden AT, Nurden P (2001) Inherited defects of platelet function. Rev Clin Exp Hematol 5:314-334; quiz 431
90. O'Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ (2001) Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 98:3256-3260
91. Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME (1996) Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet 348:1309-1310
92. Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831-843
93. Prandini MH, Denarier E, Frachet P, Uzan G, Marguerie G (1988) Isolation of the human platelet glycoprotein IIb gene and characterization of the 5′ flanking region. Biochem Biophys Res Commun 156:595-601
94. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628-1633
95. Reiner AP, Siscovick DS, Rosendaal FR (2001) Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol 5:262-287; discussion 311-262
96. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K (1997) PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385-388
97. Roest M, Banga JD, Grobbee DE, de Groot PG, Sixma JJ (2000) Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102:1645-1650
98. Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803-814
99. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
100. Ruan J, Peyruchaud O, Nurden A, Bourre F (1998) Linkage of four polymorphisms on the alphallb gene. Br J Haematol 102:622-625
101. Samani NJ, Lodwick D (1997) Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 33:693-697
102. Santoro SA (1999) Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood 93:3575-3577
103. Santoso S, Kalb R, Walka M, Kiefel V, Mueller-Eckhardt C, Newman PJ (1993) The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2). J Clin Invest 92:2427-2432
104. Santoso S, Amrhein J, Hofmann HA, Sachs UJ, Walka MM, Kroll H, Kiefel V (1999a) A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation. Blood 94:4103-4111
105. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A (1999b) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in young patients. Blood 93:2449-2453
106. Santoso S, Zimmermann P, Sachs UJ, Gardemann A (2002) The impact of the Kozak sequence polymorphism of the glycoprotein Ib alpha gene on the risk and extent of coronary heart disease. Thromb Haemost 87:345-346
107. Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289-297
108. Scaglione L, Bergerone S, Gaschino G, Imazio M, Maccagnani A, Gambino R, Cassader M, Di Leo M, Macchia G, Brusca A, Pagano G, Cavallo-Perin (1998) Lack of relationship between the PlA1/PlA2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction. Eur J Clin Invest 28:385-388
109. Shattil SJ, Kashiwagi H, Pampori N (1998) Integrin signaling: the platelet paradigm. Blood 91:2645-2657
110. Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA (2000) Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193-204
111. Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K (2000) Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke 31:493-497
112. Sonoda A, Murata M, Ikeda Y, Fukuuchi Y, Watanabe K (2001) Stroke and platelet glycoprotein Ibalpha polymorphisms. Thromb Haemost 85:573-574
113. Sperr WR, Huber K, Roden M, Janisiw M, Lang T, Graf S, Maurer G, Mayr WR, Panzer S (1998) Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 90:117-123
114. Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A (2001) Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32:2753-2758
115. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965-967
116. Tanaka S, Ohnoki S, Shibata H, Okubo Y, Yamaguchi H, Shibata Y (1996) Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese. Transfusion 36:813-817
117. Theodoropoulos I, Christopoulos C, Metcalfe P, Dimitriadou E, Economopoulos P, Loucopoulos D (2001) The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol 114:387-393
118. Thornton MA, Poncz M, Korostishevsky M, Yakobson E, Usher S, Seligsohn U, Peretz H (1999) The human platelet alphaIIb gene is not closely linked to its integrin partner beta3. Blood 94: 2039-2047
119. Undas A, Sanak M, Musial J, Szczeklik A (1999) Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet 353:982-983
120. Undas A, Brummel K, Musial J, Mann KG, Szczeklik A (2001) Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104:2666-2672
121. Van Goor ML, Gomez Garcia E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW (2002) PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 108:63-65
122. Von Beckerath N, Koch W, Mehilli J, Böttiger C, Schömig A, Kastrati A (2000) Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 95:3297-3301
123. Von Beckerath N, Koch W, Mehilli J, Bottiger C, Braun S, Schomig A, Kastrati A (2001) Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. Atherosclerosis 156:463-468
124. Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Goldschmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJI, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ (1998) Platelet glycoprotein receptor IIIa polymorphism PlA2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke 29:581-585
125. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM (1997) Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350:1217-1219
126. Walter DH, Schachinger V, Elsner M, Mach S, Dimmeler S, Auch-Schwelk W, Zeiher AM (2001) Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene. Eur Heart J 22:587-595
127. Ware J (1998) Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 79:466-478
128. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090-1094
129. Wheeler GL, Braden GA, Bray PF, Marciniak SJ, Mascelli MA, Sane DC (2002) Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. Am Heart J 143:76-82
130. Zhu MM, Weedon J, Clark LT (2000) Meta-analysis of the association of platelet glycoprotein IIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 86:1000-1005
131. Zotz RB, Winkelmann BR, Nauck M, Giers G, Maruhn-Debowski B, Marz W, Scharf RE (1998) Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen Ib (HPA-1b/ PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79:731-735